Market Tracker

08/23 5:04pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

1.17
Delayed Data
As of 3:59pm ET
 -0.02 / -1.68%
Today’s Change
0.82
Today|||52-Week Range
3.89
-47.30%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close1.19
Today’s open1.18
Day’s range1.14 - 1.19
Volume212,991
Average volume (3 months)922,595
Market cap$161.0M
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-41.18%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...+0.02+0.21%
CDXSCodexis Inc+0.06+1.45%
SNMXSenomyx Inc-0.16-3.92%
AVXLAnavex Life Sciences...+0.05+1.56%
Data as of 3:59pm ET, 08/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts